The burden of NAFLD in type 2 diabetic subjects from the general population: A Nationwide population-based follow-up study (NASHCO).
Oumarou NabiJerome BoursierNathanaël LapidusPhilippe MathurinVictor De LedinghenJean-Michel PetitMarcel GoldbergMarie ZinsKarine LacombeLawrence SerfatyPublished in: Liver international : official journal of the International Association for the Study of the Liver (2022)
This prospective, longitudinal study in a large community-based cohort provides real-world evidence of the risk for NAFLD and advanced fibrosis in diabetes, and its impact on liver disease progression, diabetes-related complications such as CVD, and overall mortality. These data could be used to estimate real clinical and economic burden of NAFLD in diabetic subjects.